71 related articles for article (PubMed ID: 21612325)
1. Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis.
Ryk C; Wiklund NP; Nyberg T; De Verdier PJ
Scand J Urol Nephrol; 2011 Nov; 45(5):319-25. PubMed ID: 21612325
[TBL] [Abstract][Full Text] [Related]
2. The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.
Ryk C; Steineck G; Wiklund NP; Nyberg T; de Verdier PJ
J Urol; 2010 Nov; 184(5):2150-7. PubMed ID: 20850837
[TBL] [Abstract][Full Text] [Related]
3. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
Redox Biol; 2015 Dec; 6():272-277. PubMed ID: 26298202
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer.
Ryk C; Wiklund NP; Nyberg T; de Verdier PJ
Nitric Oxide; 2011 Oct; 25(3):338-43. PubMed ID: 21703358
[TBL] [Abstract][Full Text] [Related]
5. Association between recurrent aphthous stomatitis and inheritance of a single-nucleotide polymorphism of the NOS2 gene encoding inducible nitric oxide synthase.
Karasneh JA; Darwazeh AM; Hassan AF; Thornhill M
J Oral Pathol Med; 2011 Oct; 40(9):715-20. PubMed ID: 21481004
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the H19 gene and the risk of bladder cancer.
Verhaegh GW; Verkleij L; Vermeulen SH; den Heijer M; Witjes JA; Kiemeney LA
Eur Urol; 2008 Nov; 54(5):1118-26. PubMed ID: 18262338
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms In The Nitric-Oxide Synthase 2 Gene And Prostate Cancer Pathogenesis.
Ryk C; de Verdier P; Montgomery E; Peter Wiklund N; Wiklund F; Grönberg H
Redox Biol; 2015 Aug; 5():419. PubMed ID: 28162285
[TBL] [Abstract][Full Text] [Related]
9. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
Mittal RD; Manchanda PK; Bhat S; Bid HK
BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.
Ouerhani S; Oliveira E; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; El Gaaied AB; Prata MJ
Cancer Genet Cytogenet; 2007 Jul; 176(1):48-53. PubMed ID: 17574963
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide.
Dahgam S; Nyberg F; Modig L; Naluai AT; Olin AC
J Med Genet; 2012 Mar; 49(3):200-5. PubMed ID: 22368302
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase and PPARγ are involved in bladder cancer progression.
Sandes EO; Lodillinsky C; Langle Y; Belgorosky D; Marino L; Gimenez L; Casabé AR; Eiján AM
J Urol; 2012 Sep; 188(3):967-73. PubMed ID: 22819108
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase-2 (NOS2) gene polymorphism c.1832C>T (Ser608Leu) associated with nitrosative stress in Fanconi anaemia.
George M; Solanki A; Mohanty P; Dhangar S; Rajendran A; Mohan S; Vundinti BR
Mol Biol Rep; 2021 Mar; 48(3):2519-2525. PubMed ID: 33778919
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase 2 (NOS2) promoter polymorphisms in colorectal cancer.
Fransén K; Elander N; Söderkvist P
Cancer Lett; 2005 Jul; 225(1):99-103. PubMed ID: 15922861
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms.
Sanyal S; Ryk C; De Verdier PJ; Steineck G; Larsson P; Onelöv E; Hemminki K; Kumar R
Scand J Urol Nephrol; 2007; 41(3):182-90. PubMed ID: 17469025
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
